Another enzyme, the Ubiquitin-conjugating enzyme E2T (UBE2T), is correlated with tumor recurrence, highly expressed in GBM, and associated with poor prognosis, EMT regulation, and invasion of GBM cells through GRP78 (Huang et al., 2020a). The gene discussed is UBE2T; the disease is neoplasm.